Apothecon Group appoints pharmaceutical industry veteran Shyamakant Giri as the Group CEO
May 15, 2026
Mumbai (Maharashtra) [India], May 15: Apothecon Group, a regulated markets-focused, speciality formulations business, today announced the appointment of Shyamakant Giri as the Group Chief Executive Officer, effective May 11, 2026. Based out of Vadodara, India, Mr. Giri will lead the next phase of growth and strategic expansion for the Group.